Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (401-410 of 595) with videos related to

Pageof 60
Sort By:
Revue Medicale De Liege|April 24, 2010
[Sugar: results of a Belgian observational study on the use of sitagliptin in patients with type 2 diabetes]A J Scheen, L F Van Gaal
Revue Medicale De Liege|April 28, 2007
[Cardiometabolic effects of rimonabant in obese/overweight subjects with dyslipidaemia or type 2 diabetes]A J Scheen, L F Van Gaal
Revue Medicale De Liege|April 11, 2001
[Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy]J C Philips, L Weekers, A J Scheen
Revue Medicale De Liege|April 16, 2003
[Islet cell transplantation: a step toward curing diabetes?]J C Philips, R Radermecker, A J Scheen
Diabetes & Metabolism|October 28, 2011
Haemodynamic changes during a squat test, pulsatile stress and indices of cardiovascular autonomic neuropathy in patients with long-duration type 1 diabetesJ-C Philips, M Marchand, A J Scheen
Revue Medicale De Liege|January 12, 2023
[A new era for glucagon-like peptide-1 receptor agonists]M F Neuville, N Paquot, A J Scheen
Diabetes/Metabolism Research and Reviews|May 14, 2009
Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetesJ C Philips, M Marchand, A J Scheen
Revue Medicale De Liege|July 8, 1999
[Gestational diabetes: definition, screening and management]I Geronooz, A J Scheen, J M Foidart
Revue Medicale De Liege|July 8, 1999
[Gestational diabetes: physiopathology and prognostic significance for the mother]I Geronooz, A J Scheen, P J Lefèbvre
Revue Medicale De Liege|August 14, 1999
[Glucotoxicity and lipotoxicity, two implicated accomplices in the vicious circle of type 2 diabetes]A J Scheen, N Paquot, P J Lefèbvre
Pageof 60

Showing results (401-410 of 595) with videos related to

Sort By:
Pageof 60
Revue Medicale De Liege|April 24, 2010
[Sugar: results of a Belgian observational study on the use of sitagliptin in patients with type 2 diabetes]A J Scheen, L F Van Gaal
Revue Medicale De Liege|April 28, 2007
[Cardiometabolic effects of rimonabant in obese/overweight subjects with dyslipidaemia or type 2 diabetes]A J Scheen, L F Van Gaal
Revue Medicale De Liege|April 11, 2001
[Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy]J C Philips, L Weekers, A J Scheen
Revue Medicale De Liege|April 16, 2003
[Islet cell transplantation: a step toward curing diabetes?]J C Philips, R Radermecker, A J Scheen
Diabetes & Metabolism|October 28, 2011
Haemodynamic changes during a squat test, pulsatile stress and indices of cardiovascular autonomic neuropathy in patients with long-duration type 1 diabetesJ-C Philips, M Marchand, A J Scheen
Revue Medicale De Liege|January 12, 2023
[A new era for glucagon-like peptide-1 receptor agonists]M F Neuville, N Paquot, A J Scheen
Diabetes/Metabolism Research and Reviews|May 14, 2009
Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetesJ C Philips, M Marchand, A J Scheen
Revue Medicale De Liege|July 8, 1999
[Gestational diabetes: definition, screening and management]I Geronooz, A J Scheen, J M Foidart
Revue Medicale De Liege|July 8, 1999
[Gestational diabetes: physiopathology and prognostic significance for the mother]I Geronooz, A J Scheen, P J Lefèbvre
Revue Medicale De Liege|August 14, 1999
[Glucotoxicity and lipotoxicity, two implicated accomplices in the vicious circle of type 2 diabetes]A J Scheen, N Paquot, P J Lefèbvre
Pageof 60